Cancer Monthly Warns: Actos Not the Only Drug That May Pose Bladder...
The Japanese drug maker that was recently ordered to pay $6 billion to a man who claimed that his bladder cancer diagnosis was caused by Actos, makes several other drugs with the same active...(PRWeb April 16, 2014)Read the full story at http://www.prweb.com/releases/2014/04/prweb11763969.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 17, 2014 Category: Pharmaceuticals Source Type: news
Cancer Monthly Advises Actos Users to Know the Symptoms of Bladder...
In the wake of a federal jury’s decision to award $9 billion to a man who developed bladder cancer after using the diabetes drug Actos, Cancer Monthly says patients who took Actos should recognize the...(PRWeb April 17, 2014)Read the full story at http://www.prweb.com/releases/2014/04/prweb11766224.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 17, 2014 Category: Pharmaceuticals Source Type: news
Bad week for Big Pharma!
Three revelations reveal unacceptable deep corruption in pharma companies (Source: Alliance for Natural Health)
Source: Alliance for Natural Health - April 16, 2014 Category: Complementary Medicine Authors: Sophie Tags: Actos Alltrials Bad Pharma ben goldacre Big pharme Bite the Sun BMJ British Medical Journal Cochrane Collaboration corruption diabetes Dr Peter Gøtzsche Eli Lilly & amp; Co. europe GlaxoSmithKline GSK international M Source Type: news
Actos Appeal No Reason for Bladder Cancer Patients to Delay, According...
The cancer information website Cancer Monthly says bladder cancer patients who took Actos should not wait to seek legal advice, despite drug maker’s plans to appeal a federal jury’s ruling.(PRWeb April 15, 2014)Read the full story at http://www.prweb.com/releases/2014/04/prweb11760993.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 16, 2014 Category: Pharmaceuticals Source Type: news
New York Law Firm Rudolph F.X. Migliore, P.C. Reports a U.S. Jury...
Takeda pharmaceutical company and marketing partner Eli Lilly have now been ordered by a Federal Court to pay for a Plaintiff's cancer injuries in connection with the drug Actos. A jury rewarded...(PRWeb April 15, 2014)Read the full story at http://www.prweb.com/releases/2014/04/prweb11762747.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 16, 2014 Category: Pharmaceuticals Source Type: news
Scientific Evidence Backs up Actos Jury’s Findings, According to...
A recent published review of the link between Actos and bladder cancer suggests that a federal jury’s judgment against the drug’s manufacturer is justified.(PRWeb April 14, 2014)Read the full story at http://www.prweb.com/releases/2014/04/prweb11759460.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 14, 2014 Category: Pharmaceuticals Source Type: news
Verdict Gives Bladder Cancer Actos Users Reason for Action, According...
Days after a federal jury announced a $9 billion dollar judgment against the drug’s manufacturers, Cancer Monthly is encouraging bladder cancer patients to know their rights.(PRWeb April 13, 2014)Read the full story at http://www.prweb.com/releases/2014/04/prweb11750188.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 13, 2014 Category: Pharmaceuticals Source Type: news
Verdict Could Mean Help for Bladder Cancer Patients Who Have Used...
A Louisiana jury’s decision to award $9 billion in damages to a man who says his bladder cancer was caused by the drug Actos could pave a new legal path for other bladder cancer patients.(PRWeb April 12, 2014)Read the full story at http://www.prweb.com/releases/2014/04/prweb11754749.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 12, 2014 Category: Pharmaceuticals Source Type: news
Takeda, Lilly Fined $9B for Hiding Cancer Risks
A Louisiana federal court ordered Takeda Pharmaceutical Co. and Eli Lilly & Co. to pay a combined $9 billion in punitive damages after a jury found they covered up the cancer risks of their Actos diabetes drug. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - April 10, 2014 Category: Pharmaceuticals Source Type: news
Jury Hits Pioglitazone Makers With $9 Billion in DamagesJury Hits Pioglitazone Makers With $9 Billion in Damages
Drugmakers Takeda Pharmaceutical Co. And Elli Lilly and Co. promised to appeal a $9 billion award when a federal jury found they had concealed cancer risks of pioglitazone. Medscape Medical News (Source: Medscape Business of Medicine Headlines)
Source: Medscape Business of Medicine Headlines - April 10, 2014 Category: Pharmaceuticals Tags: Diabetes & Endocrinology News Source Type: news
Takeda And Lilly Hit With $9 Billion Penalty Over ACTOS Trial
Takeda and Eli Lilly announced that a U.S. jury found its ACTOS case in favor of the plaintiffs and awarded $9 billion in punitive damages from the companies. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - April 9, 2014 Category: Pharmaceuticals Source Type: news
Actos Makers to Pay $9 Billion: Flood Law Group Investigates Lawsuits
Takeda Pharmaceuticals and marketing partner Eli Lilly & Co. were ordered to pay a total of $9 billion in punitive damages for allegedly withholding information about the potential risks...(PRWeb April 08, 2014)Read the full story at http://www.prweb.com/releases/actos-bladder-cancer/flood-law-group/prweb11746425.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 9, 2014 Category: Pharmaceuticals Source Type: news
Journal Report Says Prompt Diagnosis Key to Surviving Bladder Cancer,...
A new UK report on the early warning signs of bladder cancer is especially relevant for diabetics and those who have taken Actos.(PRWeb April 02, 2014)Read the full story at http://www.prweb.com/releases/2014/03/prweb11715160.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 2, 2014 Category: Pharmaceuticals Source Type: news
New Actos Lawsuit Alleges Bladder Cancer: Now, AttorneyOne Can Provide...
A new lawsuit filed on March 17, by a woman in Missouri Eastern District Court alleges that her father died from bladder cancer as a result of ingesting Actos. In light of this news, AttorneyOne, a...(PRWeb April 01, 2014)Read the full story at http://www.prweb.com/releases/2014/04/prweb11726746.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 2, 2014 Category: Pharmaceuticals Source Type: news
Meta-Analysis Fails to Rule Out Bladder Cancer Risk with Actos,...
An Italian study of 22 clinical trials contains some good news and some bad news for diabetic patients treated with the drug Actos.(PRWeb March 23, 2014)Read the full story at http://www.prweb.com/releases/2014/03/prweb11669870.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 23, 2014 Category: Pharmaceuticals Source Type: news
